Momentus shares surged nearly 20% in overnight trading ahead of Tuesday, extending a rally that sent MNTS stock up 35.4% last week. The latest spike followed a more than 21% jump last Thursday after SpaceX disclosed it had confidentially submitted IPO paperwork to regulators.
John Rood, Momentus’s chief executive, has positioned the company at the center of the move: on May 5 he told shareholders the company was targeting $10 million in revenue this year — a ninefold increase over $1.1 million in 2025 — and noted Momentus had raised $5 million in a private placement and had become debt-free. “Momentus enters the remainder of 2026 with a fully operational spacecraft on-orbit, a sold-out next mission, a strengthened balance sheet, active contracts with the nation’s top defense agencies, and a facility built to scale,” Rood wrote.
The rally carries real weight: MNTS stock added 35.4% last week after the SpaceX disclosure and that momentum has drawn fresh retail and institutional attention. Several top Momentus executives — CEO John Rood, CTO Rob Schwarz, CFO Lon Ensler, legal chief Jon Layman and board member Brian Kabot — recently acquired company stock, a move investors cited as a signal of insider confidence behind the price action.
Fundamentally, Momentus can point to concrete developments. Its Vigoride 7 vehicle launched on SpaceX's Transporter-16 mission in March and is operating with payloads for NASA and the U.S. Air Force. The company says Vigoride 8 has completed its Preliminary Design Review, is planned for 2027 and is already fully booked with NASA-backed payloads. Momentus is also developing in-space servicing and orbital assembly technologies under programs linked to NASA and DARPA, and the firm says much of its expected revenue growth will come from milestone-based contracts with NASA and the U.S. Department of Defense.
Context is simple and immediate: the stock move comes amid a broader surge in investor interest in space stocks tied to anticipation around the SpaceX IPO. On Stocktwits, sentiment for MNTS was described as “extremely bullish” early Tuesday, and traders point to the cascading effect an IPO of a dominant industry player can have across smaller firms in the sector.
That enthusiasm overlaps with a clear tension. The market bid has been driven as much by sector momentum and the psychological effect of a potential SpaceX listing as by Momentus’s current revenue base. The $10 million target Rood set is ambitious — a ninefold jump from $1.1 million — and depends on milestone payments and successful execution of contracted missions. An unnamed trader summed up the dynamic plainly: "When a monster entity like SpaceX (SPCX) goes public, it brings an enormous amount of institutional capital and retail eyeballs to the aerospace sector." For a micro-cap, low-float name like Momentus, that can magnify moves in both directions.
There are concrete near-term items the market will watch. Momentum from Vigoride 7’s on-orbit operations and the timing of milestone-based payments from NASA and defense contracts will determine whether the company can convert promises into the $10 million Rood forecast. The firm’s capital position — including the $5 million private placement and its debt-free status — gives it some runway, but it must translate activity into revenue before investor patience wanes.
For now, MNTS stock is riding a wave of sector enthusiasm and insider buying, while Momentus points to on-orbit hardware, a sold-out next mission and government-linked contracts as reasons the rally is more than speculative. The market’s next verdict will hinge on a single test: can Momentus deliver the milestone revenues and mission results that make a ninefold revenue increase real instead of aspirational?
